Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,533,777 papers from all fields of science
Search
Sign In
Create Free Account
sulconazole
Known as:
1-(beta-(4''-chlorobenzylthio)-2'4'-dichlorophenethyl)imidazole
, 1-[2-[[(4-chlorophenyl)methyl]thio]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole
, sulconazole [Chemical/Ingredient]
A topical imidazole derivative with broad-spectrum antifungal and antibacterial activity. Sulconazole is excreted in both the feces and urine.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Broader (2)
Antifungal Agents
Imidazoles
Azoles
Cutaneous Candidiasis
Hypersensitivity
Mycoses
Expand
Narrower (2)
Myk
Sulconazole nitrate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Stereospecific modulation of dimeric rhodopsin
Tamar Getter
,
S. Gulati
,
R. Zimmerman
,
Yuanyuan Chen
,
F. Vinberg
,
K. Palczewski
The FASEB Journal
2019
Corpus ID: 163165591
The classic concept that GPCRs function as monomers has been challenged by the emerging evidence of GPCR dimerization and…
Expand
2017
2017
Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library
Hongxia Niu
,
Chao Ma
,
+7 authors
Ying Zhang
Emerging Microbes &Infections
2017
Corpus ID: 4859943
Identification of drug candidates that enhance pyrazinamide activity from a clinical compound library
2011
2011
Generic systems for the enantioseparation of basic drugs in NACE using single-isomer anionic CDs.
A. Rousseau
,
Florian Gillotin
,
+4 authors
A. Servais
Journal of Pharmaceutical and Biomedical Analysis
2011
Corpus ID: 37175085
1994
1994
Measurement and modulation of cytochrome-P450-dependent enzyme activity in cultured human keratinocytes.
F. Raffali
,
A. Rougier
,
R. Roguet
Skin Pharmacology
1994
Corpus ID: 23879409
The metabolism of xenobiotics by the epidermis can be studied in vitro by using keratinocyte cultures. We present a simple and…
Expand
1992
1992
In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
J. Molina
,
J. Los�
,
A. Martinez Brocal
,
A. Ventosa
Mycopathologia
1992
Corpus ID: 22618209
The in vitro activity of several new imidazoles, cloconazole, sulconazole, butoconazole, isoconazole and fenticonazole, were…
Expand
1992
1992
Allergic contact dermatitis due to sulconazole
Andrea Stefano Bkiardi
,
Paolo Daniele Pigatto
,
G. Altomare
Contact Dermatitis
1992
Corpus ID: 3048556
In February 1989, a 63-year-old man, with lumbar intervertebral degenerative arthritis, presented with maculopapular to purpuric…
Expand
1991
1991
The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats.
J. V. van Cutsem
American Journal of Obstetrics and Gynecology
1991
Corpus ID: 31778692
1988
1988
Imidazole Cross‐sensitivity to sulconazole
A. Carmichael
,
I. Foulds
Contact Dermatitis
1988
Corpus ID: 20779008
Ammals were not sensitized w1th the 0.3% aq. and 1% aq. lm!dazolidinyl urea concentratiOns. One gumea p1g per test group was…
Expand
1986
1986
A Study in Industry of Bifonazole (1% Gel) and Sulconazole Cream in Tinea Pedis and Tinea Cruris
D. J. Thomas
,
A. Evans
1986
Corpus ID: 68014789
A single blind randomised trial was carried out in 106 industrial workers presenting with tinea pedis and/or tinea cruris…
Expand
1985
1985
Influence of growth phase on the susceptibility of Candida albicans to butoconazole, oxiconazole, and sulconazole.
W. Beggs
Journal of Antimicrobial Chemotherapy
1985
Corpus ID: 33422018
Three topical antifungal imidazoles were examined for fungicidal potential. At 8 X 10(-5) M, butoconazole, oxiconazole, and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE